- Investing Ideas
- /
- German Pharmaceuticals & Biotech High Growth Potential Companies
German Pharmaceuticals & Biotech High Growth Potential Companies
Results
7
Companies with a Future performance score of at least 3, ordered by Future performance score.
7 companies
Cantourage Group
Market Cap: €64.3m
Operates as a medical cannabis company in Europe.
HIGH
€5.16
7D
0%
1Y
-23.6%
SynBiotic
Market Cap: €24.5m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€3.59
7D
0%
1Y
-55.1%
Gerresheimer
Market Cap: €1.7b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€49.00
7D
1.5%
1Y
-51.5%
Evotec
Market Cap: €1.3b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€7.27
7D
0.3%
1Y
-22.5%
Apontis Pharma
Market Cap: €90.0m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€10.85
7D
0%
1Y
23.0%
Formycon
Market Cap: €509.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€28.05
7D
1.8%
1Y
-48.3%
Bayer
Market Cap: €25.7b
Operates as a life science company worldwide.
BAYN
€27.18
7D
2.7%
1Y
7.2%